Phesgo 600 mg/ 600 mg and 1200 mg/ 600 mg solution for injection
*Company:
Roche Registration GmbHStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 28 August 2024
File name
Phesgo PIL_II.0023G_25 Jul 2024.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 28 August 2024
File name
Phesgo SmPC_II.0023G_25 Jul 2024.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 25 January 2023
File name
Phesgo SmPC dated 13 Jan 2022_Clean.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 March 2022
File name
Phesgo PIL dated 13 Jan 2022_Clean.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 01 March 2022
File name
Phesgo SmPC dated 13 Jan 2022_Clean.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 16 November 2021
File name
SmPC Phego II-007_ 23.Sep.2021 clean.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 July 2021
File name
SmPC Phesgo clean - 24-Jun-2021.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 06 January 2021
File name
Phesgo SmPC Clean 21 Dec2020.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 06 January 2021
File name
Phesgo PIL Clean 21 Dec 2020.pdf
Reasons for updating
- New PIL for new product